Filing Details
- Accession Number:
- 0001104659-23-024810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-23 17:01:37
- Reporting Period:
- 2023-02-22
- Accepted Time:
- 2023-02-23 17:01:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1867066 | Journey Medical Corp | DERM | Pharmaceutical Preparations (2834) | 471879539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1887515 | Joseph Benesch | C/O Journey Medical Corporation, 9237 E Via Deventura Blvd., Suite 105 Scottsdale AZ 85258 | Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Disposition | 2023-02-22 | 2,768 | $1.97 | 67,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- In connection with the vesting of shares on February 20, 2023, a total of 2,768 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 21, 2023, was $1.95 to $1.98. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price.
- Includes restricted stock units, which vest over various time periods.
Billionaire Hedge Funds
